La bourse est fermée

Mirion Technologies, Inc. (MIR)

NYSE - NYSE Prix différé. Devise en USD
Ajouter à la liste dynamique
10,74+0,03 (+0,28 %)
À la clôture : 04:00PM EDT
10,74 0,00 (0,00 %)
Échanges après Bourse : 07:21PM EDT

Mirion Technologies, Inc.

1218 Menlo Drive
Atlanta, GA 30318
United States
770 432 2744
https://www.mirion.com

Secteur(s)Industrials
Secteur d’activitéSpecialty Industrial Machinery
Employés à temps plein2 800

Dirigeants clés

NomTitrePayerExercéAnnée de naissance
Mr. Thomas D. LoganFounder, Medical Group President, CEO & Director1,87MS.O.1961
Mr. Brian SchopferChief Financial Officer1,14MS.O.1985
Mr. Loic EloyGroup President of Technologies626,84kS.O.1977
Mr. Christopher Moore CPAChief Accounting Officer & Principal Accounting OfficerS.O.S.O.1972
Mr. James CocksChief Technology OfficerS.O.S.O.S.O.
Mr. Alex GaddySenior VP of Strategy & IR and TreasurerS.O.S.O.S.O.
Ms. Emmanuelle LeeExecutive VP, General Counsel, Secretary & Chief Legal OfficerS.O.S.O.S.O.
Ms. Erin SchesnyChief Marketing OfficerS.O.S.O.S.O.
Ms. Alison UlrichChief Human Resources OfficerS.O.S.O.S.O.
Ms. Shelia WebbChief Digital OfficerS.O.S.O.S.O.
Les montants ont été établis en date du 31 décembre 2023 et les valeurs de compensation concernent le dernier exercice fiscal clos à cette date. Le terme « rémunération » désigne le salaire, les bonus, etc. Le terme « exercé » est utilisé pour la valeur des options exercées au cours de l’exercice fiscal. Devise exprimée en USD.

Description

Mirion Technologies, Inc. provides radiation detection, measurement, analysis, and monitoring products and services in the United States, Canada, the United Kingdom, France, Germany, Finland, China, Belgium, Netherlands, Estonia, South Korea, and Japan. It operates through two segments, Medical and Technologies. The Medical segment offers radiation oncology quality assurance and dosimetry solutions; patient safety solutions for diagnostic imaging and radiation therapy centers; radiation therapy quality assurance solutions for calibrating and verifying imaging and treatment accuracy; and radionuclide therapy products for nuclear medicine applications, such as shielding, product handling, medical imaging furniture, and rehabilitation products. This segment supports applications in medical diagnostics, cancer treatment, practitioner safety, and rehabilitation. The Technologies segment focuses on addressing critical radiation safety, measurement, and analysis applications; and provides personal radiation detection, identification equipment, and analysis tools. The company's products and solutions also include nuclear medicines, dosimeters, contamination and clearance monitors, reactor instrumentation and control equipment and systems, medical and industrial imaging systems and related accessories, alpha spectroscopy instruments, alpha/beta counting instruments, and gamma spectroscopy detector systems; and electrical penetration, cancer diagnostics, software, and other services. It serves hospitals, clinics and urgent care facilities, dental and veterinary offices, radiation treatment facilities, OEMs for radiation therapy, laboratories, military organizations, government agencies, industrial companies, power and utility companies, reactor design firms, and NPPs. The company was formerly known as Global Monitoring Systems, Inc. and changed its name to Mirion Technologies, Inc. in January 2006. The company was incorporated in 2005 and is headquartered in Atlanta, Georgia.

Gouvernance d’entreprise

L’ISS Governance QualityScore de Mirion Technologies, Inc. en date du 1 juin 2024 est 4. Les scores principaux sont Audit : 2; Société : 5; Droits des actionnaires : 6; Compensation : 5.

Résultats de gouvernance d’entreprise offerts par Institutional Shareholder Services (ISS). Les résultats indiquent un rang décile par rapport à l’indice ou à la région. Un résultat décile de 1 indique un risque de gouvernance faible, tandis que 10 indique un risque de gouvernance élevé.